Shin Simon C, Thomas Divya, Radhakrishnan Prakash, Hollingsworth Michael A
The Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
The Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, USA; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, 68198, USA; Department of Genetics Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Biochem Biophys Res Commun. 2020 Feb 18. doi: 10.1016/j.bbrc.2020.02.018.
Metabolic reprogramming is required for tumors to meet the bioenergetic and biosynthetic demands of malignant progression. Numerous studies have established a causal relationship between oncogenic drivers and altered metabolism, most prominently aerobic glycolysis, which supports rapid growth and affects the tumor microenvironment. Less is known about how the microenvironment modulates cancer metabolism. In the present study, we found that low extracellular pH, a common feature of solid tumors, provoked PDAC cells to decrease glycolysis and become resistant to glucose starvation. This was accompanied by increased dependency on mitochondrial metabolism, in which long-chain fatty acids became a primary fuel source. Consistent with previous reports, low pH enhanced tumor cell invasiveness. A novel finding was that limiting PDAC metabolic flexibility by either suppression of oxidative phosphorylation capacity or the pharmacological inhibition of fatty-acid oxidation prevented invasion induced by low extracellular pH. Altogether, our results suggest for the first time that targeting fatty-acid oxidation may be a viable adjunct strategy for preventing metastatic progression of pancreatic cancer mediated by the acidic tumor compartment.
肿瘤需要进行代谢重编程以满足恶性进展的生物能量和生物合成需求。大量研究已证实致癌驱动因素与代谢改变之间存在因果关系,其中最显著的是有氧糖酵解,它支持肿瘤快速生长并影响肿瘤微环境。关于微环境如何调节癌症代谢,我们了解得较少。在本研究中,我们发现细胞外低pH值(实体瘤的一个常见特征)促使胰腺导管腺癌(PDAC)细胞减少糖酵解并对葡萄糖饥饿产生抗性。这伴随着对线粒体代谢的依赖性增加,其中长链脂肪酸成为主要燃料来源。与先前报道一致,低pH值增强了肿瘤细胞的侵袭性。一个新发现是,通过抑制氧化磷酸化能力或脂肪酸氧化的药理学抑制来限制PDAC的代谢灵活性,可防止细胞外低pH值诱导的侵袭。总之,我们的结果首次表明,靶向脂肪酸氧化可能是预防酸性肿瘤微环境介导的胰腺癌转移进展的一种可行辅助策略。